|?|| (G;G) (G;T) (T;T) ||28|
] Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
[PMID 21319151] Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.
[PMID 23408108] Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy.
[PMID 24803183] Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival